↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

26 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名（臨床試験情報から抽出）   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   Anastrozole  2件: Anastrozole; Arimidex (anastrozole);   D00960   1件: CYP19A1   3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis   3件:
78,
86,
193
 2   Beloranib  2件: Beloranib; Subcutaneous beloranib in suspension;   -   -   -   1件:
193
 3   Cannabidiol  6件: Cannabidiol; Cannabidiol (cbd); Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol capsule 5 mg; Cannabidiol oral solution; Cannabidiol tablet 10 mg;   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   14件:
2,
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271
 4   Cannabidivarin  -  -   -   -   1件:
193
 5   Carbetocin  3件: Carbetocin; Intranasal carbetocin dose 1; Intranasal carbetocin dose 2;   D07229   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   1件:
193
 6   Chloride ion  -  -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299
 7   Choline  6件: Bis-choline tetrathiomolybdate; Choline; Choline chloride; Choline supplementation; Diazoxide choline controlled-release tablet; Vitamin: choline bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1;   D07690   -   -   4件:
65,
171,
193,
299
 8   Corticotropin  8件: Corticotropin; Corticotropin releasing hormone; Corticotropin-releasing hormone; H.p. acthar gel (repository corticotropin injection); H.p. acthar® gel (repository corticotropin injection); Ovine corticotropin-releasing hormone (ocrh); Repository corticotropin injection; Repository corticotropin injection -treatment extension;   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   12件:
2,
13,
46,
49,
50,
66,
75,
78,
84,
145,
193,
222
 9   Diazoxide  2件: Diazoxide; Diazoxide choline controlled-release tablet;   D00294   2件: ABCC8, KCNJ11   4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus   1件:
193
 10   Exenatide  3件: Exenatide; Exenatide 10 micrograms; Exenatide 5 micrograms;   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
6,
193,
233
 11   Guanfacine  2件: Guanfacine; Guanfacine extended release (gxr);   D00606
 D08031 		  1件: ADRA2A   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
193
 12   Liraglutide  1件: Liraglutide;   D06404   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
6,
75,
193
 13   Livoletide  1件: Livoletide;   -   -   -   1件:
193
 14   Medical air  4件: Medical air; Medical air (sham o2); Medical air vs oxygen; Sham o2 (medical air);   -   -   -   3件:
85,
86,
193
 15   Metoprolol  6件: Metoprolol; Metoprolol succinate; Metoprolol succinate + doxazosin; Metoprolol tartrate 50 mg; Metoprolol tartrate oral tablet; Tesofensine/metoprolol;   D00601
 D02358
 D05011 		  1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   7件:
17,
57,
58,
66,
113,
193,
226
 16   Metyrapone  1件: Metyrapone;   D00410
 D05019 		  1件: CYP11B1   4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis   2件:
75,
193
 17   Octreotide  5件: Gallium-68-dota-n-octreotide; Octreotide; Octreotide lar; Octreotide lar / sandostatin lar (lar=long acting release); Octreotide-lar;   D00442
 D06495 		  1件: SSTR2   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   8件:
67,
75,
84,
85,
89,
96,
193,
227
 18   Oxygen  9件: Continuous oxygen; Helium / oxygen mixed gas inhalation therapy; Medical air vs oxygen; Medical grade oxygen; Nitric oxide plus oxygen; Oxygen; Oxygen 40 %; Oxygen supplementation; Perfluorinated gas/oxygen mixture;   D00003   -   -   18件:
5,
6,
17,
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
211,
226,
299,
330
 19   Oxytocin  6件: Intranasal oxytocin; Intranasal oxytocin (in-oxt); Oxytocin; Oxytocin (oxt) continuous; Oxytocin 24iu; Oxytocin 48iu;   D00089   1件: OXTR   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   4件:
127,
193,
206,
226
 20   Rimonabant  1件: Rimonabant;   D05731   1件: CNR1   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   1件:
193
 21   Sodium chloride  14件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); 0.9% sodium chloride injection; 0.9% w/v sodium chloride solution; Isotonic sodium chloride solution; Physiological serum (sodium chloride); Sodium chloride; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 6%; Sodium chloride solution; Sodium chloride solution 0.9%; Sodium chloride solvent; Sodium pyruvate in 0.9% sodium chloride solution;   D02056   -   -   19件:
6,
11,
13,
14,
17,
34,
46,
51,
53,
67,
78,
86,
97,
168,
193,
227,
228,
288,
299
 22   Somatotropin  2件: Recombinant human somatotropin; Somatotropin;   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   18件:
2,
3,
13,
19,
46,
74,
75,
78,
96,
113,
191,
193,
195,
236,
265,
274,
276,
299
 23   Tesofensine  3件: 1. tesofensine (ns 2330); Tesofensine; Tesofensine/metoprolol;   -   -   -   2件:
6,
193
 24   Topiramate  2件: Topiramate; Topiramate (drug);   D00537   36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   48件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
6,
140,
144,
156,
193
 25   Ubidecarenone  -  D01065   -   -   12件:
2,
5,
6,
8,
10,
46,
57,
86,
113,
193,
214,
215
 26   Water  13件: 15 o water; 15-o labeled water; 5% glucose water solution; Dextrose, 5% in water; High water intake; Lactose in water; Pl 12185/0002 & pl 12185/0005(water for injection); Pseudoephedrine + 480 ml water; Pseudoephedrine + 50 ml water; Water; Water for injection; Water for injections; Water for injections, ep;   D00001   -   -   22件:
2,
5,
6,
13,
17,
19,
28,
35,
46,
53,
57,
63,
65,
67,
78,
84,
97,
193,
226,
271,
278,
299

先頭へ